Deczuba 50 mg Injection Substitute
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
Composition:
DECITABINE-50MG
Uses:
Deczuba 50 mg Injection is used to treat blood and bone marrow disorders. The detailed uses of Deczuba 50 mg Injection are as follows:<br/>• Treats myelodysplastic syndrome (MDS): Deczuba 50 mg Injection helps manage a group of conditions where the bone marrow makes misshapen or insufficient healthy blood cells.<br/>• Promotes healthy blood cell production: Deczuba 50 mg Injection aids the bone marrow in producing normal blood cells.<br/>• Targets abnormal bone marrow cells: Deczuba 50 mg Injection works by destroying abnormal cells in the bone marrow to improve overall blood health.<br/>
Medicinal Benefits:
Deczuba 50 mg Injection belongs to the group of medicines called hypomethylation agents used to treat myelodysplastic syndrome. Deczuba 50 mg Injection contains ‘Decitabine’, which works by helping the bone marrow produce normal blood cells and kills abnormal cells in the bone marrow. On the other hand, it can treat blood cancer, known as acute myeloid leukemia (AML).
Deczuba 50 mg Injection is used to treat Myelodysplastic syndrome.
Deczuba 50 mg Injection contains Decitabine, which works by helping the bone marrow produce normal blood cells and by killing abnormal cells in the bone marrow.
Decitabine therapy should usually be given as a three- or five-day regimen based on your medical condition and response to the treatment. Do not stop taking Deczuba 50 mg Injection on your own. Do not be reluctant to speak with your doctor if you experience any difficulty while taking Deczuba 50 mg Injection.
Deczuba 50 mg Injection can be used to treat blood cancer known as acute myeloid leukemia (AML).
Deczuba 50 mg Injection therapy may cause a change in skin colour or pale skin or red spots on the skin. Consult your doctor immediately if you notice these symptoms persistently.
Deczuba 50 mg Injection might cause neutropenia (low white blood cells) and thrombocytopenia (low platelets). Blood count should be checked regularly during treatment with Deczuba 50 mg Injection.
Decitabine may raise blood sugar. If you have high blood sugar (diabetes), talk with your doctor.
No, Deczuba 50 mg Injection is not a vesicant. It is an anti-cancer drug that is not known to cause severe tissue damage when it leaks from the injection site into surrounding tissues. It belongs to the group of medications called hypo methylation agents used to treat myelodysplastic syndrome.
Deczuba 50 mg Injection effectively treats myelodysplastic syndrome, a group of disorders in which the bone marrow produces misshapen blood cells and insufficient healthy blood cells. It works by promoting the production of normal blood cells in the bone marrow and eliminating abnormal cells. However, the degree of effectiveness varies among individuals based on their medical condition.
Yes, Deczuba 50 mg Injection may cause hair loss as a common side effect. To cope with hair loss, manage stress, maintain a healthy diet, avoid harsh hair treatments, use gentle hair care products, and consider medical treatments or therapies as advised by a doctor.
Deczuba 50 mg Injection is administered through an intravenous route (into a vein) slowly over 3 hours by the doctor or nurse. It is usually administered every 8 hours for 3 days depending on the prescribed dose and treatment plan.
The side effects of Deczuba 50 mg Injection include vomiting, nausea, injection site reactions, excessive tiredness, headache, dizziness, confusion, fast heartbeat, difficulty falling asleep or staying asleep, weakness, shortness of breath, constipation, diarrhoea, heartburn, chest discomfort and swelling of the hands, feet, ankles, lower legs, or stomach. Consult the doctor if any of these side effects persist or worsen.